Found 19 matching trials
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
PHASE2The study is designed to test the hypothesis that the clinical complete res...
Location
Fudan University Shanghai Cancer Cencer
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
PHASE2A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Location
Mayo Clinic Cancer Center
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
PHASE2To explore the efficacy and safety of radiotherapy followed by PD-1+ standa...
Location
Multiple Locations
TACE Combined With Sorafenib and Tislelizumab for Advanced HCC
PHASE2This study will evaluate the efficacy and safety of transcatheter arterial ...
Location
The 2nd Affiliated Hospital of Guangzhou Medical University
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
PHASE2This is an open-label, parallel group, non-randomized, multicenter phase II...
Status
Active Not Recruiting
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
PHASE2This study is a single-arm, open-label, prospective, and exploratory invest...
Location
The First Affiliated Hospital of Xiamen University
Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC
PHASE2Perioperative chemotherapy improves overall survival (OS) and disease-free ...
Location
The First Affiliated Hospital of Zhengzhou University
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
PHASE2This is a randomized controlled, phase II clinical study designed to explor...
Location
Shanghai First People's Hospital
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
N/AThe aim of this study is to the efficacy, prognosis, adverse effects, and f...
Location
The Second Affiliated Hospital of Fujian Medical University